2-[(E)-4-methoxy-benzenesulfonylimino]-imidazolidine-1-carbodithioic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4]thiadiazol-7-yl ester

ID: ALA208987

PubChem CID: 24205067

Max Phase: Preclinical

Molecular Formula: C15H16N6O3S5

Molecular Weight: 488.67

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(S(=O)(=O)NC2=NCCN2C(=S)SN2CCn3c2nsc3=S)cc1

Standard InChI:  InChI=1S/C15H16N6O3S5/c1-24-10-2-4-11(5-3-10)29(22,23)18-12-16-6-7-19(12)15(26)28-21-9-8-20-13(21)17-27-14(20)25/h2-5H,6-9H2,1H3,(H,16,18)

Standard InChI Key:  WAGGPKJMAYNWJX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    1.4130   -5.4660    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1856   -5.7630    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.7049   -5.1220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4584   -4.6448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2571   -4.4288    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2986   -3.6037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5259   -3.3068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0066   -3.9516    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5300   -5.1636    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.1855   -3.9062    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2298   -3.1928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0527   -3.1928    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1855   -2.4794    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5391   -2.5264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3243   -2.7814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3243   -3.6043    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5391   -3.8592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2840   -4.6444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8706   -5.2310    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2840   -5.8137    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4533   -4.6444    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4533   -5.8137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2460   -5.5989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8284   -6.1808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6153   -6.9778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8146   -7.1896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2355   -6.6061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1963   -7.5603    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9823   -8.3548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  7  1  0
  7  8  1  0
  8  4  1  0
  3  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 22 23  2  0
  1  2  1  0
 23 24  1  0
  2  3  1  0
 24 25  2  0
  3  5  1  0
 25 26  1  0
  4  1  2  0
 26 27  2  0
 27 22  1  0
  4  5  1  0
 25 28  1  0
  5  6  1  0
 28 29  1  0
M  END

Associated Targets(Human)

KYSE-510 (286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RXF 393 (41971 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UO-31 (46270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 488.67Molecular Weight (Monoisotopic): 487.9887AlogP: 2.09#Rotatable Bonds: 4
Polar Surface Area: 92.06Molecular Species: NEUTRALHBA: 11HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.03CX Basic pKa: 1.68CX LogP: 3.61CX LogD: 3.61
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -1.46

References

1. Saczewski J, Brzozowski Z, Saczewski F, Bednarski PJ, Liebeke M, Gdaniec M..  (2006)  Synthesis and in vitro anti-tumor activity of N-{1-[(3-thioxo-5,6-dihydroimidazo[2,1-c][1,2,4]thiadiazol-7-ylthio)thiocarbonyl]-2-imidazolidene}arylsulfonamides.,  16  (14): [PMID:16682194] [10.1016/j.bmcl.2006.04.067]

Source